Advertisement
Advertisement

BBNX

BBNX logo

Beta Bionics, Inc. Common Stock

14.39
USD
Sponsored
+0.52
+3.75%
Jun 09, 16:00 UTC -4
Closed
exchange

After-Market

14.50

+0.11
+0.76%

Beta Bionics, Inc. Common Stock Profile

About

Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif.

Info & Links

CEO

Sean Saint

Headquarters

11 HUGHES
IRVINE, CA 92618, UNITED STATES

Industry

Medical Instruments

Sector

Medical

Website

https://www.betabionics.com/

Auditor

Ernst & Young LLP

Share holders

674

Employees

420

Beta Bionics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

646.10M

Enterprise Value

615.79M

Enterprise Value/EBITDA(ttm)

-8.32

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

4.26

Price to Book(mrq)

1.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

54.78%

Operating Margin(ttm)

-60.60%

Profit Margin(ttm)

-82.28%

Return on Equity(ttm)

-20.29%

Return on Invested Capital(ttm)

-24.23%

Return on Assets(ttm)

-18.32%

Income Statement

Revenue(ttm)

110.24M

Revenue Per Share(ttm)

2.47

Gross Profit(ttm)

63.00M

EBITDA(ttm)3

-74.05M

Net Income Available to Common(ttm)

-66.44M

Diluted EPS(ttm)

-1.95

Share Statistics

Beta (5Y Monthly)

5.06

52-Week Change

-24.58%

S&P 500 52-Week Change

22.99%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

44.56M

Dividend Yield

0.00%

Float4

0.00

% Held by Insiders

--

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

199.62M

Total Cash Per Share(mrq)

4.48

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

8.66%

Quick Ratio(mrq)

7.96%

Book Value Per Share(mrq)

6.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.26

Free Cash Flow(ytd)

-332.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement